GenFleet Therapeutics closes bookbuilding round with $349b

Chinese drugmaker GenFleet Therapeutics (Shanghai) has attracted HK$349.8 billion from retail bookbuilding which closed on Tuesday at noon, making it 2,211 times oversubscribed.

The biopharmaceutical company aims to raise HK$1.58 billion in total and is scheduled to list on Friday.

The firm plans to issue 77.6 million shares at HK$20.39 per share, with a minimum investment of HK$4,119.10 per board lot of 200 shares.

HELEN ZHONG